Reporter March 15 2013

Photo: Discovery Lecture

Scott Hultgren, Ph.D., director of the Center for Women’s Infectious Disease Research at Washington University in St. Louis, talked about improving therapies for urinary tract infections during his recent Flexner Discovery Lecture.

Balser outlines efforts to address shifting economy

An overview of financial pressures created by the federal budget sequester and other legislation now facing Vanderbilt University Medical Center and academic health centers across the country was presented March 12 at two leadership forums — the Spring Clinical Enterprise Leadership Assembly held that morning at Langford Auditorium, and a faculty meeting focused on impact on the research community the same afternoon in Light Hall.

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.

Bacterial resistance breaks bridges

Understanding how bacteria become resistant to quinolone antibiotics could guide strategies for developing new antibacterial drugs.

VUSM ranked among nation’s top schools

Vanderbilt University School of Medicine is once again named among the nation’s elite Research Schools of Medicine in U.S. News & World Report magazine’s 2014 “Best Graduate Schools” rankings, released this week.

1 2